Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Clifford

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Neuropeptides|October 1, 1982
The ability of RX 77368 - a stabilised analogue of TRH - to provoke the secretion of prolactin and TSH in vivoP W Dettmar, A G Lynn, G Metcalf, et al.
Psychopharmacology|December 21, 1976
The relationship between the anticonvulsant properties of SC-13504 and its plasma levels, measured by polarography, in baboons with photosensitive epilepsyB S Meldrum, M R Smyth, W Franklin-Smyth, et al.
Journal of Pharmacological Methods|September 1, 1987
The use of ex vivo platelet aggregation to confirm the in vivo alpha 2-adrenoreceptor antagonist effect of idazoxan in manN C Muir, J C Doxey, M E Havler, et al.
European Journal of Clinical Pharmacology|January 1, 1986
The pharmacokinetics after intravenous and oral administration in man of the alpha 2-adrenoreceptor antagonist idazoxan (RX781094)N C Muir, J G Lloyd-Jones, J D Nichols, et al.
Current Medical Research and Opinion|January 1, 1997
The influence of dosage form on aspirin kinetics: implications for acute cardiovascular useN Muir, J D Nichols, J M Clifford, et al.
Biochemical Pharmacology|February 15, 1973
Biochemical and pharmacological actions of imidazoleacetic acidJ M Clifford, P V Taberner, G Tunnicliff, et al.
European Journal of Clinical Pharmacology|January 1, 1981
Pharmacokinetics of intravenous and oral tolmesoxideJ G Lloyd-Jones, R Henson, J D Nichols, et al.
Journal of Clinical Psychopharmacology|April 1, 1989
Naloxone suppresses buprenorphine stimulation of plasma prolactinJ H Mendelson, N K Mello, S K Teoh, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Neuropeptides|October 1, 1982
The ability of RX 77368 - a stabilised analogue of TRH - to provoke the secretion of prolactin and TSH in vivoP W Dettmar, A G Lynn, G Metcalf, et al.
Psychopharmacology|December 21, 1976
The relationship between the anticonvulsant properties of SC-13504 and its plasma levels, measured by polarography, in baboons with photosensitive epilepsyB S Meldrum, M R Smyth, W Franklin-Smyth, et al.
Journal of Pharmacological Methods|September 1, 1987
The use of ex vivo platelet aggregation to confirm the in vivo alpha 2-adrenoreceptor antagonist effect of idazoxan in manN C Muir, J C Doxey, M E Havler, et al.
European Journal of Clinical Pharmacology|January 1, 1986
The pharmacokinetics after intravenous and oral administration in man of the alpha 2-adrenoreceptor antagonist idazoxan (RX781094)N C Muir, J G Lloyd-Jones, J D Nichols, et al.
Current Medical Research and Opinion|January 1, 1997
The influence of dosage form on aspirin kinetics: implications for acute cardiovascular useN Muir, J D Nichols, J M Clifford, et al.
Biochemical Pharmacology|February 15, 1973
Biochemical and pharmacological actions of imidazoleacetic acidJ M Clifford, P V Taberner, G Tunnicliff, et al.
European Journal of Clinical Pharmacology|January 1, 1981
Pharmacokinetics of intravenous and oral tolmesoxideJ G Lloyd-Jones, R Henson, J D Nichols, et al.
Journal of Clinical Psychopharmacology|April 1, 1989
Naloxone suppresses buprenorphine stimulation of plasma prolactinJ H Mendelson, N K Mello, S K Teoh, et al.
Pageof 2